Cargando…

Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer

PURPOSE: To investigate the consequences of residual setup error on target dose distribution using various image registration strategies for breast cancer treated with intensity-modulated proton therapy (IMPT). MATERIALS AND METHODS: Among 11 post-lumpectomy patients who received IMPT, 44 dose distr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Xiaoying, Mailhot Vega, Raymond B., Li, Zuofeng, Zheng, Dandan, Mendenhall, Nancy, Bradley, Julie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045466/ https://www.ncbi.nlm.nih.gov/pubmed/32103762 http://dx.doi.org/10.1186/s13014-020-01495-6

Ejemplares similares

A comprehensive dosimetric study of Monte Carlo and pencil‐beam algorithms on intensity‐modulated proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

RBE‐weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy
por: Liu, Chunbo, et al.
Publicado: (2022)

Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Proton Therapy for Bilateral Breast Cancer Maximizes Normal-Tissue Sparing
por: Brooks, Eric D., et al.
Publicado: (2023)

Incidence of Rib Fracture following Treatment with Proton Therapy for Breast Cancer
por: Bradley, Julie A., et al.
Publicado: (2023)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
por: Looi, Wen Shen, et al.
Publicado: (2022)

Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer
por: Pedersen, Jesper, et al.
Publicado: (2021)

Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques
por: Su, Zhong, et al.
Publicado: (2019)

Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)

Robust optimization of VMAT for lung cancer: Dosimetric implications of motion compensation techniques
por: Archibald‐Heeren, Ben R., et al.
Publicado: (2017)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

RONC-24. PROTON THERAPY FOR PEDIATRIC EPENDYMOMA: MATURE OUTCOMES FROM THE UNIVERSITY OF FLORIDA AND MASSACHUSETTS GENERAL HOSPITAL
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Intensity-modulated radiotherapy for whole pelvis irradiation in prostate cancer: A dosimetric and plan robustness study between photons and protons
por: Ong, Ashley L.K., et al.
Publicado: (2018)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

RONC-22. SECOND TUMORS IN PEDIATRIC PATIENTS TREATED WITH PROTON THERAPY TO THE CENTRAL NERVOUS SYSTEM
por: Indelicato, Daniel J, et al.
Publicado: (2020)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments
por: den Otter, Lydia A., et al.
Publicado: (2018)

Dosimetric Comparison of Various Spot Placement Techniques in Proton Pencil Beam Scanning
por: ur Rehman, Mahboob, et al.
Publicado: (2022)

Dosimetric Importance of the Implementation of Daily Image Guidance in Radiotherapy Practice
por: T, Hridya V, et al.
Publicado: (2022)

Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization
por: Ge, Shuaiping, et al.
Publicado: (2019)

A Beam-Angle-Selection Method to Improve Inter-Fraction Motion Robustness for Lung Tumor Irradiation With Passive Proton Scattering
por: Zhang, Yawei, et al.
Publicado: (2020)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies
por: Jie, Ang Wei, et al.
Publicado: (2020)

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma
por: Yu, Nathan Y, et al.
Publicado: (2019)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

A fast robust optimizer for intensity modulated proton therapy using GPU
por: Xu, Yao, et al.
Publicado: (2020)

Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report
por: Liu, I-Chia, et al.
Publicado: (2020)

Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture
por: Su, Zhong, et al.
Publicado: (2020)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Racial and Ethnic Demographic Reporting in Phase 2 Proton Therapy Clinical Trials: A Review
por: Fakhry, Jonathan S., et al.
Publicado: (2023)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy
por: Feng, Zhongsu, et al.
Publicado: (2015)

Dosimetric Characteristics of Radiophotoluminescent Glass Dosimeters for Proton Beams
por: Oonsiri, Sornjarod, et al.
Publicado: (2023)

Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp
por: Mizuno, Tomoki, et al.
Publicado: (2021)

Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
por: Takaoka, Taiki, et al.
Publicado: (2021)

Dosimetric Parameters Related to Acute Radiation Dermatitis of Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Proton Therapy
por: Fang, Ko-Chun, et al.
Publicado: (2022)

Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer
por: Lu, Jia-Yang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4fmv3743fmsvlbif9n4309sn5s